The research led by Ottawa's Dr. Guy Trudel is one of four new Canadian studies to be conducted aboard the International ...

Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ―― Live and ...

Calcium and iron supplements can interact with each other. Taking them at different times of the day may be necessary to ...

Modus Therapeutics Holding AB (publ) ("Modus" or the "Company") announces that the competent authorities in Italy have approved the Company's dose selection for its ...

Scott Adams, creator of Dilbert, pleaded with President Donald Trump for help after his cancer diagnosis, Kennedy responded.

Progress has been made in identifying and treating the disease, but the impact of federal cuts is yet to be borne out.

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...

Abcuro, Inc., a late-stage clinical biotechnology company developing potential first-in-class immunotherapies for the benefit of people living with debilitating and progressive rare autoimmune ...

For Jane, a failed breathalyzer and a DUI charge despite being sober were not a mistake, but a symptom of a rare medical ...

Vitamin C enhances iron absorption, and taking vitamin C with some other nutrients may help enhance the effects of each.

New professional guidance to the nation's pediatricians advises against using a drug in children with autism that many families are clamoring for after it was hyped by federal officials.

86% ORR, 63% CR rate, 53% PFS at 12 months in patients who received vispa-cel with an optimized profile (N=35) Vispa-cel is generally well-tolerated, allowing for administration in the outpatient ...